"pancreatic disorders" trang 11 - tải miễn phí từ tailieuXANH
Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nabpaclitaxel therapy in metastatic pancreatic cancer

Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nabpaclitaxel therapy in metastatic pancreatic cancer
9    67    0
Screening differentially expressed genes of pancreatic cancer between Mongolian and Han people using bioinformatics technology

Screening differentially expressed genes of pancreatic cancer between Mongolian and Han people using bioinformatics technology
11    53    0
Unexpected response to palliative radiotherapy for subcutaneous metastases of an advanced small cell pancreatic neuroendocrine carcinoma: A case report of two different radiation schedules

Unexpected response to palliative radiotherapy for subcutaneous metastases of an advanced small cell pancreatic neuroendocrine carcinoma: A case report of two different radiation schedules
7    53    0
Prognostic significance of stem cell/ epithelial-mesenchymal transition markers in periampullary/pancreatic cancers: FGFR1 is a promising prognostic marker

Prognostic significance of stem cell/ epithelial-mesenchymal transition markers in periampullary/pancreatic cancers: FGFR1 is a promising prognostic marker
14    77    0
Validation and modification of staging systems for poorly differentiated pancreatic neuroendocrine carcinoma

Validation and modification of staging systems for poorly differentiated pancreatic neuroendocrine carcinoma
8    52    0
Correlation of skin rash and overall survival in patients with pancreatic cancer treated with gemcitabine and erlotinib – results from a non-interventional multi-center study

Correlation of skin rash and overall survival in patients with pancreatic cancer treated with gemcitabine and erlotinib – results from a non-interventional multi-center study
8    73    0
Searching for novel multimodal treatments in oligometastatic pancreatic cancer

Searching for novel multimodal treatments in oligometastatic pancreatic cancer
5    52    0
Quality of life study of patients with unresectable locally advanced or metastatic pancreatic adenocarcinoma treated with gemcitabine+nab-paclitaxel versus gemcitabine alone: AX-PANC-SY001, a randomized phase-2 study

Quality of life study of patients with unresectable locally advanced or metastatic pancreatic adenocarcinoma treated with gemcitabine+nab-paclitaxel versus gemcitabine alone: AX-PANC-SY001, a randomized phase-2 study
7    71    0
The A818–6 system as an in-vitro model for studying the role of the transportome in pancreatic cancer

The A818–6 system as an in-vitro model for studying the role of the transportome in pancreatic cancer
17    64    0
Dynamic serum alkaline phosphatase is an indicator of overall survival in pancreatic cancer

Dynamic serum alkaline phosphatase is an indicator of overall survival in pancreatic cancer
8    63    0
Fatal myositis and spontaneous haematoma induced by combined immune checkpoint inhibitor treatment in a patient with pancreatic adenocarcinoma

Fatal myositis and spontaneous haematoma induced by combined immune checkpoint inhibitor treatment in a patient with pancreatic adenocarcinoma
5    41    0
Comparison of tumour and serum specific microRNA changes dissecting their role in pancreatic ductal adenocarcinoma: A metaanalysis

Comparison of tumour and serum specific microRNA changes dissecting their role in pancreatic ductal adenocarcinoma: A metaanalysis
21    55    0
TIMP-2 secreted by monocyte-like cells is a potent suppressor of invadopodia formation in pancreatic cancer cells

TIMP-2 secreted by monocyte-like cells is a potent suppressor of invadopodia formation in pancreatic cancer cells
14    50    0
Early relapse on adjuvant gemcitabine associated with an exceptional response to 2nd line capecitabine chemotherapy in a patient with pancreatic adenosquamous carcinoma with strong intra-tumoural expression of cytidine deaminase: A case report

Early relapse on adjuvant gemcitabine associated with an exceptional response to 2nd line capecitabine chemotherapy in a patient with pancreatic adenosquamous carcinoma with strong intra-tumoural expression of cytidine deaminase: A case report
6    61    0
Identification of dissociation factors in pancreatic Cancer using a mass spectrometry-based proteomic approach

Identification of dissociation factors in pancreatic Cancer using a mass spectrometry-based proteomic approach
9    51    0
PDAC-ANN: An artificial neural network to predict pancreatic ductal adenocarcinoma based on gene expression

PDAC-ANN: An artificial neural network to predict pancreatic ductal adenocarcinoma based on gene expression
11    70    0
The impact of neoadjuvant and adjuvant immunotherapy on the survival of pancreatic cancer patients: A retrospective analysis

The impact of neoadjuvant and adjuvant immunotherapy on the survival of pancreatic cancer patients: A retrospective analysis
10    121    0
MicroRNAs in Pancreatic Cancer: Biomarkers, prognostic, and therapeutic modulators

MicroRNAs in Pancreatic Cancer: Biomarkers, prognostic, and therapeutic modulators
13    54    0
Irreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: A propensity score analysis

Irreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: A propensity score analysis
11    79    0
High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma

High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma
11    57    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.